Itaconix raises 2026 revenue outlook after record first half

What has Itaconix announced?

Itaconix has upgraded its revenue outlook after delivering what it describes as a record first half of 2026.

The plant-based specialty polymers company generated unaudited revenue of $8.3 million in the six months ended 30 June 2026. That was 72% higher than the $4.8 million reported for the first half of 2025 and 46% ahead of the $5.7 million generated in the second half of last year.

Growth was achieved across all major product segments, rather than being tied to a single product or geography. That breadth is encouraging, although investors should note management's warning that customer reorder rates are not yet firmly established.

The board now expects revenue for the year ending 31 December 2026 to be no less than $14.8 million. This is ahead of the $13.3 million analyst forecast cited in the announcement.

Itaconix's key figures

Metric	H1 2026	Comparison
Unaudited revenue	$8.3 million	Up 72% against H1 2025
H1 2025 revenue	$4.8 million	Prior-year comparison
H2 2025 revenue	$5.7 million	H1 2026 was 46% higher
Expected gross profit margin	36%	In line with FY 2025
FY 2026 revenue guidance	At least $14.8 million	Above cited analyst forecast of $13.3 million
FY 2026 EBITDA outlook	Small positive result	Unchanged

EBITDA means earnings before interest, tax, depreciation and amortisation. It is commonly used to assess a company's underlying operating performance, although it is not the same as cash flow or statutory profit.

The upgraded revenue guidance is around 11% above the $13.3 million analyst forecast referenced by Itaconix. That is a meaningful increase, particularly given that it has been issued shortly after the halfway point of the year.

What is driving the growth?

Performance Ingredients

The Performance Ingredients segment, which mainly serves the dish detergent market, performed well across both EMEA and North America.

Itaconix said growth came from strong reorder volumes among existing customers, alongside two new customer wins. These included a unit-dose dish detergent customer in EMEA and a unit-dose laundry detergent customer in North America.

This combination matters. Repeat orders can indicate that products are moving beyond trials and into regular use, while new customer additions expand the potential revenue base.

However, the announcement does not disclose how much revenue came from each customer, the duration of any arrangements or expected future order values. Investors therefore cannot yet judge the concentration or visibility of this demand.

SPARX Formulated Solutions

SPARX Formulated Solutions also grew as its formulations were used more widely in North American solid unit-dose dish and laundry detergents.

Itaconix generates revenue here by selling other key ingredients needed by contract manufacturers to produce SPARX formulations. In practical terms, growth depends on manufacturers producing more detergent products using these formulations and buying the associated ingredients from Itaconix.

No separate SPARX revenue figure or growth rate was disclosed.

Margins are holding steady

The expected gross profit margin for the first half is 36%, in line with the full-year 2025 level.

Gross profit margin measures the proportion of revenue left after direct production costs. Maintaining the margin while revenue rises sharply suggests that growth has not been secured simply by accepting substantially weaker unit economics.

Management attributed the margin performance to robust handling of raw materials and supply chains. This is a positive feature of the update, although investors will have to wait for the interim results for fuller cost and profitability details.

The company did not disclose first-half EBITDA, statutory profit, cash flow, net cash or debt in this trading update.

What does the guidance imply for the second half?

With $8.3 million already generated in the first half, revenue of at least $14.8 million for the full year implies second-half sales of at least $6.5 million.

That would be below the record first-half level, but above the $5.7 million delivered in the second half of 2025. The guidance therefore does not require Itaconix to repeat its first-half performance in full.

This may indicate a degree of caution from the board, particularly because reorder rates have yet to be firmly established. It also provides some room for customer ordering patterns to fluctuate during the remainder of the year.

The company continues to expect a small positive EBITDA result for 2026. Before this announcement, analyst forecasts cited by the board indicated EBITDA of $0.3 million. Itaconix has not provided a more precise updated EBITDA figure.

Management said profitability would reflect strategic investment in headcount and product development. Revenue is rising quickly, but part of the benefit is being reinvested to support near-term expansion and longer-term opportunities.

Longer-term opportunities remain at an early stage

Itaconix is progressing opportunities beyond its established detergent activities.

BIO*Asterix specialty monomers and binders are being developed for high-value paints, while BioVail is a new plant nutrition ingredient intended for crop production.

These products could broaden the company's addressable markets and reduce its reliance on detergent-related demand. However, the announcement describes them as longer-term revenue opportunities and does not disclose sales, customer agreements, launch dates or expected commercial contributions.

Investors should therefore treat paints and agriculture as potential growth options rather than material contributors confirmed within the current guidance.

The positives and risks for investors

The clearest positive is the pace of revenue growth. First-half sales increased sharply against both halves of 2025, with contributions across major product segments and both existing and new customers.

The revenue upgrade is also notable. Guidance of at least $14.8 million is comfortably ahead of the $13.3 million market expectation cited by the company, while the 36% gross margin has been maintained.

The main uncertainty is revenue visibility. Itaconix explicitly said reorder rates are not yet firmly established. A strong opening order from a new customer does not necessarily guarantee the same volume or timing in future periods.

Investors also have limited information on customer concentration, cash generation and the cost of planned investment. The expectation of only a small positive EBITDA result shows that rapid revenue growth is not yet translating into a large operating profit.

My take

This is a strong trading update from Itaconix. Record first-half revenue, broad-based growth, a stable gross margin and upgraded full-year guidance all point to improving commercial momentum.

The key question is now whether customer reorders can turn that momentum into dependable, repeatable revenue. Investors will also want evidence that scale is improving profitability after allowing for additional staff and product development spending.

The interim results, expected on or about 8 September 2026, should provide a more complete picture of margins, operating costs and financial position. For now, the direction of travel is encouraging, but the limited visibility over repeat demand remains the most important point to watch.